ReNeuron Group plc (RNUGF)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -7.48 Million | -7.41 Million | -6.05 Million | -14.3 Million | -11.99 Million | -14.88 Million |
| Net Income | -6.65 Million | -11.05 Million | -13.41 Million | -13.85 Million | -17.17 Million | -20.96 Million |
| Depreciation & Amortization | 267 Thousand | 324 Thousand | 380 Thousand | 412 Thousand | 282 Thousand | 232 Thousand |
| Deferred income taxes | 1.43 Million | 1.78 Million | 6.02 Million | -653 Thousand | 3.12 Million | 4.35 Million |
| Stock-based compensation | 576 Thousand | 649 Thousand | 764 Thousand | 1.2 Million | 1.04 Million | 1.12 Million |
| Change in working capital | -2.64 Million | 1.05 Million | -307 Thousand | -857 Thousand | 1.83 Million | -227 Thousand |
| Other non-cash items | -458 Thousand | -170 Thousand | 496 Thousand | -551 Thousand | -1.1 Million | 591 Thousand |
| Investing Cash Flow | 4.91 Million | -276 Thousand | 2000.00 | 181 Thousand | 154 Thousand | 148 Thousand |
| Investments in PPE | -220 Thousand | -302 Thousand | -25 Thousand | -119 Thousand | -188 Thousand | -235 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | 5 Million | 2.5 Million | - | - | - | - |
| Other Investing Activities | 131 Thousand | -2.47 Million | 27 Thousand | 300 Thousand | 342 Thousand | 383 Thousand |
| Financing Cash Flow | -147 Thousand | 2.36 Million | 8.61 Million | 6.31 Million | 4.35 Million | 14.52 Million |
| Debt repayment | -148 Thousand | -157 Thousand | -154 Thousand | -12 Thousand | -51 Thousand | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 1000.00 | 23 Thousand | 17.5 Million | 188 Thousand | - | - |
| Other Financing Activities | -148 Thousand | 2.34 Million | -8.89 Million | 6.14 Million | 4.41 Million | 14.52 Million |
| Accounts receivables | 58 Thousand | -90 Thousand | 245 Thousand | 126 Thousand | 397 Thousand | -289 Thousand |
| Accounts payables | -2.7 Million | 1.14 Million | -552 Thousand | -983 Thousand | 1.44 Million | 62 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | -2.7 Million | - | - | - | 1000.00 | - |
| Cash at beginning of period | 9.54 Million | 14.7 Million | 12.62 Million | 20.43 Million | 27.91 Million | 28.12 Million |
| Cash at end of period | 7.15 Million | 9.54 Million | 14.7 Million | 12.62 Million | 20.43 Million | 27.91 Million |
| Capital Expenditure | -220 Thousand | -302 Thousand | -25 Thousand | -119 Thousand | -188 Thousand | -235 Thousand |
| Effect of forex changes on cash | 326 Thousand | 166 Thousand | -483 Thousand | 167 Thousand | - | - |
| Net cash flow / Change in cash | -2.39 Million | -5.15 Million | 2.07 Million | -7.8 Million | -7.47 Million | -214 Thousand |
| Free Cash Flow | -7.7 Million | -7.71 Million | -6.07 Million | -14.42 Million | -12.18 Million | -15.12 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -1.42 Million | -1.42 Million | -6.65 Million | -2.23 Million | -1.11 Million | -3.17 Million |
| Depreciation & Amortization | 64.5 Thousand | 64.5 Thousand | 267 Thousand | 135 Thousand | 67.5 Thousand | 132 Thousand |
| Deferred income taxes | -706.5 Thousand | - | 1.43 Million | -2.48 Million | - | -987 Thousand |
| Stock-based compensation | 102.5 Thousand | 102.5 Thousand | 576 Thousand | 103 Thousand | 103 Thousand | 185 Thousand |
| Change in working capital | 81.5 Thousand | 81.5 Thousand | -2.64 Million | -2.11 Million | -14.5 Thousand | -538 Thousand |
| Other non-cash items | 121.5 Thousand | 121.5 Thousand | -458 Thousand | 3.52 Million | -620.5 Thousand | 93 Thousand |
| Investing Cash Flow | 555 Thousand | 555 Thousand | 4.91 Million | 3.93 Million | 2.01 Million | -156 Thousand |
| Investments in PPE | - | - | -220 Thousand | -64 Thousand | -32 Thousand | -156 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | 5 Million | - | - | - |
| Other Investing Activities | 555 Thousand | 555 Thousand | 131 Thousand | 4 Million | 2.04 Million | 2.01 Million |
| Financing Cash Flow | -38 Thousand | -38 Thousand | -147 Thousand | -4.08 Million | -2.04 Million | 3.93 Million |
| Debt repayment | - | - | -148 Thousand | -7000.00 | - | -7000.00 |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | 1000.00 | 1000.00 | - | - |
| Other Financing Activities | -38 Thousand | -38 Thousand | -148 Thousand | -4 Million | -2.04 Million | 4 Million |
| Accounts receivables | 81.5 Thousand | 81.5 Thousand | 58 Thousand | -29 Thousand | -14.5 Thousand | 87 Thousand |
| Accounts payables | -509 Thousand | - | -2.7 Million | -2.08 Million | - | -625 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | - | - | - | - | - | - |
| Cash at beginning of period | 6.15 Million | - | 9.54 Million | 9.46 Million | 9.46 Million | 9.54 Million |
| Cash at end of period | 5.07 Million | -539 Thousand | 7.15 Million | 6.15 Million | 7.8 Million | 9.46 Million |
| Capital Expenditure | - | - | -220 Thousand | -64 Thousand | -32 Thousand | -156 Thousand |
| Effect of forex changes on cash | -5500.00 | -5500.00 | 326 Thousand | -52 Thousand | -52 Thousand | 214.5 Thousand |
| Net cash flow / Change in cash | -1.07 Million | -539 Thousand | -2.39 Million | -3.31 Million | -1.65 Million | -84 Thousand |
| Free Cash Flow | -1.05 Million | -1.05 Million | -7.7 Million | -3.12 Million | -1.61 Million | -4.44 Million |
CVX
JPDYY
VOXX
USFD
6902
CLVLF